Institutional Giants Surge as Promoter Sells Stake in Anthem Biosciences; Stock Climbs Near 4%
Anthem Biosciences saw a significant movement on June 18 following a high-volume block deal involving the company's promoter group. Aruna Ganesh successfully sold a 3.05 percent stake, comprising 1.71 crore shares, through this transaction. The sale occurred at a price of Rs 744.8 per share.The blockbuster move was counterbalanced by massive interest from both domestic and foreign institutional investors (FIIs) during the block deal. HDFC Mutual Fund and Kotak Mahindra Mutual Fund were notable among the buyers who acquired 13.43 lakh shares each. SBI Mutual Fund also emerged as a major buyer, purchasing 26.95 lakh shares.
Other key institutions participating in the demand included UTI Mutual Fund and Bajaj Life Insurance, with both acquiring 13.43 lakh shares apiece. ICICI Prudential Life Insurance secured 12.08 lakh shares, while international players like Prudential Hong Kong (10.2 lakh shares) and Nordea 1 SICAV - Indian Equity Fund (6.85 lakh shares) were also present in the transaction.
Closing strong amidst these significant institutional purchases, Anthem Biosciences stock traded at Rs 799.80 on the day. This performance indicates a nearly 4 percent rise for the specialized CRO/CDMO company.
Institutional Demand Drives Stock Rally in Anthem Biosciences
Anthem Biosciences operates as a critical contract research, development, and manufacturing organization (CRDMO). It provides essential services such as drug discovery, development, and manufacturing to both global pharmaceutical and biotechnology giants. The sustained interest from major mutual funds underscores the market's confidence in the specialized sector.Diversified Bulk Deals on Stock Exchanges
Beyond the main focus of Anthem Biosciences, the trading day saw several high-volume bulk deals across various sectors. These transactions covered entities ranging from consumer goods to financial services.Investment Flows and Outcomes for Signoria Creation
Holani Venture Capital Fund-I successfully purchased 1.8 lakh shares of Signoria Creation at Rs 76.2 per share, constituting a transaction valued at approximately Rs 1.37 crore. Signoria Creation is recognized in the apparel market for manufacturing and marketing women's wear, including kurtis, dresses, and co-ord sets under the Signoria brand globally.Motisons Jewellers Sees Fund Sell-Off
Tiger Strategies Fund-I sold a substantial quantity of 90.5 lakh shares of Motisons Jewellers. The sale occurred at Rs 14.25 per share, amounting to around Rs 12.9 crore. Jaipur based, Motisons Jewellers is involved in the retail trade of gold and diamond jewellery, complemented by silver articles and other lifestyle products through its network.Goldline Pharmaceutical Transaction Details
A segment sale was reported for Goldline Pharmaceutical, with Vikasa India EIF I Fund - Share Class P selling 1.5 lakh shares at Rs 44 per share. The transaction generated approximately Rs 66 lakh. Goldline Pharmaceutical markets under the brand name and addresses multiple segments like cardiology, gastroenterology, neurology, diabetology, and paediatrics, distributing through an extensive network across India.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.